Levy Harold J 4
4 · ENZON PHARMACEUTICALS INC · Filed Mar 10, 2010
Insider Transaction Report
Form 4
Levy Harold J
Director
Transactions
- Conversion
4% Convertible Senior Notes Due 2013
2010-02-18−116,535→ 0 total(indirect: By Trust)From: 2009-07-23Exp: 2013-06-01→ Common Stock (116,535 underlying) - Conversion
Common Stock
2010-02-18+116,535→ 166,535 total(indirect: By Trust)
Footnotes (2)
- [F1]In accordance with the terms of the Issuer's 4% Convertible Senior Notes Due 2013 held by the Reporting Person (the "Notes"), the Reporting Person elected to convert the Notes into the Issuer's Common Stock at the conversion rate of 116.535 shares per $1,000 in principal amount of the Notes.
- [F2]The Reporting Person's beneficial ownership includes 50,000 shares held directly by the Reporting Person.